Transcriptional evidence for the role of chronic venlafaxine treatment in neurotrophic signaling and...
Transcriptional evidence for the role of chronic venlafaxine treatment in neurotrophic signaling and neuroplasticity including also Glutamatergic [corrected] - and insulin-mediated neuronal processes
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science (PLoS)
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science (PLoS)
Subjects
More information
Scope and Contents
Contents
Venlafaxine (VLX), a serotonine-noradrenaline reuptake inhibitor, is one of the most commonly used antidepressant drugs in clinical practice for the treatment of major depressive disorder (MDD). Despite being more potent than its predecessors, similarly to them, the therapeutical effect of VLX is visible only 3-4 weeks after the beginning of treatm...
Alternative Titles
Full title
Transcriptional evidence for the role of chronic venlafaxine treatment in neurotrophic signaling and neuroplasticity including also Glutamatergic [corrected] - and insulin-mediated neuronal processes
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_5b79e46adffc4898bb059aa151b1e61c
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5b79e46adffc4898bb059aa151b1e61c
Other Identifiers
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0113662
